Septagen Pharmaceuticals

Advancing First-in-Class Dual Anti-Thrombotic and Anti-Inflammatory Therapeutics. At Septagen, we are committed to developing innovative PAR4 antagonists targeting thrombinflammation By targeting PAR4 overexpression in inflammatory states, we aim to develop therapies that address the root cause of... Read more